Assessing the Prognosis of TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for HCC by Using Clinical and Imaging Biomarkers

TACE Combined With Sintilimab and Bevacizumab for Unresectable HCC

NCT04592029 ·Status: UNKNOWN ·Phase: PHASE1

TACE Combined With Bevacizumab in HCC (BCLC-B) Beyond Up-To-Seven Criteria

NCT05883176 ·Status: UNKNOWN ·Phase: PHASE2

TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone for Hepatocellular Carcinoma With PVTT

NCT05535998 ·Status: COMPLETED

Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study

NCT04975932 ·Status: COMPLETED

EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial

NCT07187284 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Efficacy, Safety, and Treatment Patterns of Transcatheter Arterial Chemoembolization (TACE) Combined With Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma: a Multicenter, Retrospective, Observational Real-world Study

NCT06024252 ·Status: UNKNOWN

Different Protocols for Repeated Transarterial Chemoembolization in the Treatment of Patients With Hepatocellular Carcinoma

NCT02038296 ·Status: COMPLETED ·Phase: PHASE3

TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.

NCT06669377 ·Status: RECRUITING

Drug-eluting Bead Transarterial Chemoembolisation (DEB-TACE) Versus (VS) Conventional Transarterial Chemoembolisation (cTACE) for Unresectable Hepatocellualr Carcinoma (HCC)

NCT03969576 ·Status: UNKNOWN ·Phase: NA

HAIC vs. TACE Combined With ICIs and TKIs in Intermediate-to-Advanced HCC: A Multicenter Study on Liver Injury and Survival

NCT07277192 ·Status: COMPLETED

Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo

NCT07239245 ·Status: RECRUITING ·Phase: PHASE2

DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC

NCT06190665 ·Status: RECRUITING ·Phase: NA

Survival Analysis: TACE vs. Combination Therapy in HCC

NCT06261138 ·Status: COMPLETED

TACE With Immune Agents for Angiogenesis in Hepatocellular Carcinoma

NCT07053202 ·Status: COMPLETED ·Phase: NA

Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients

NCT02956772 ·Status: UNKNOWN ·Phase: PHASE2

DEB-TACE+HAIC vs. HAIC for Large HCC

NCT05263219 ·Status: RECRUITING ·Phase: PHASE3

TACE Combined with Anti-PD-1 Antibody in Patients with Advanced Hepatocellular Carcinoma

NCT04297280 ·Status: COMPLETED ·Phase: PHASE2

TACE Combined With Lenvatinib and Sintilimab for Advanced HCC

NCT04599790 ·Status: COMPLETED ·Phase: PHASE2

TACE Versus HAIC, Combined With PD-1 Inhibitors and Lenvatinib for Unresectable Hepatocellular Carcinoma

NCT07340502 ·Status: NOT_YET_RECRUITING

The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma

NCT04997850 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC

NCT05025592 ·Status: UNKNOWN

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

NCT02631499 ·Status: UNKNOWN ·Phase: PHASE4

Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma

NCT02150317 ·Status: UNKNOWN ·Phase: NA

Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas (TACE-KMG)

NCT01393197 ·Status: UNKNOWN ·Phase: NA

Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas

NCT01393093 ·Status: UNKNOWN ·Phase: NA